Title : Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiation.

Pub. Date : 2007 Oct 1

PMID : 17909054






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The antineoplastic drug sorafenib (BAY 43-9006) is a multikinase inhibitor that targets the serine-threonine kinase B-Raf as well as several tyrosine kinases. Sorafenib B-Raf proto-oncogene, serine/threonine kinase Homo sapiens
2 The antineoplastic drug sorafenib (BAY 43-9006) is a multikinase inhibitor that targets the serine-threonine kinase B-Raf as well as several tyrosine kinases. Sorafenib B-Raf proto-oncogene, serine/threonine kinase Homo sapiens